Hand OA affects the interphalangeal and thumb base joints, including the CMC-1 and STT joints. Much is still unknown about the pathophysiology of thumb base OA. Although MRI studies have led to more insights in interphalangeal OA, thumb base MRI studies are still lacking. To facilitate this, recently the first MRI scoring system for thumb base OA was developed by the OMERACT MRI Working Group, the TOMS.[@R1]

Representative examples of each grade of the different features that are assessed in the TOMS are presented (see [table 1](#T1){ref-type="table"} for definitions and scaling of each feature). Images from patients with hand OA were obtained from the Hand Osteoarthritis in Secondary Care (HOSTAS) study at Leiden University Medical Center (Leiden, The Netherlands). Images were acquired on a 1.5 T extremity MRI unit (ONI, GE, Wisconsin, USA). Examples of synovitis evaluated on contrast-enhanced images were obtained from patients with hand OA from the Nor-Hand study at Diakonhjemmet Hospital (Oslo, Norway) and were acquired on a 1.5 T MRI unit (Siemens Aera, Germany) after administration of gadolinium contrast. Example images were selected by a single reader with experience in using the TOMS and subsequently approved by three experienced radiologists (of which one is also experienced in using the score).

###### 

Definitions and scaling of features in proposed OMERACT TOMS

  MRI feature                  Definition                                                                                                                                                                                                           Scaling                                                                                                                                                                                                                                                                                                                                                                                                                                                    Suggested plane and MRI sequence
  ---------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------
  Synovitis†                   Thickened synovium with enhancement after Gd injection.                                                                                                                                                              0=normal; 1=mild (1%--33%); 2=moderate (34%--66%); 3=severe (67%--100%). Based on thirds of the presumed maximum thickness of enhancing tissue in the synovial compartment.                                                                                                                                                                                                                                                                                Coronal and axial. T1w pre-Gd and post-Gd with fs. In the absence of post-Gd images T2w-fs/STIR/PD-fs can be used.
  Subchondral bone defects†‡   Subchondral bone loss, including erosions (sharply marginated bone lesions with cortical break), cysts (sharply marginated bone lesions without cortical break) and bone attrition (diffuse loss of bone contour).   0=no bone defects; 1=mild (≤25% of bone volume or joint surface affected); 2=moderate (26%--50% of bone volume or joint surface affected); 3=severe (\>50% of bone volume or joint surface affected).                                                                                                                                                                                                                                                      Coronal and axial. T1w and T2w-fs/STIR/PD-fs.
  Osteophytes‡                 Abnormal bone protuberance at joint margins or surfaces.                                                                                                                                                             0=no osteophytes; 1=mild (1--2 small osteophytes); 2=moderate (≥3 small osteophytes and/or≥1 moderate osteophyte(s)); 3=severe (≥1 large osteophyte(s)).                                                                                                                                                                                                                                                                                                   Coronal (and sagittal if available). T1w.
  Cartilage assessment         Loss of cartilage or loss of cartilage space based on the interbone distance¶.                                                                                                                                       0=no loss of cartilage or cartilage space; 1=mild (cartilage loss without complete denuding, or cartilage space loss without bone-to-bone contact); 2=moderate (cartilage loss with denuding ≤50% of joint surface or focal complete cartilage space loss with bone-to-bone contact ≤50% of the articulating area); 3=severe (cartilage loss with denuding \>50% of joint surface or complete cartilage space loss over \>50% of the articulating area).   Coronal. T1w-fs-3D-GE, otherwise use T1w-fs, T2w-fs or PD-fs.
  Subluxation§                 Subluxation of the CMC-1 joint in the frontal plane.                                                                                                                                                                 0=MC-1 subluxed 0%--25% of the MC-width; 1=MC-1 subluxed ≥26% of the MC-width.                                                                                                                                                                                                                                                                                                                                                                             Coronal. T1w.
  Bone marrow lesions†‡        Lesions within the trabecular bone with signal characteristic consistent with increased water content\*\* and with ill-defined margins.                                                                              0=no bone marrow lesions; 1=mild (1%--33% bone volume); 2=moderate (34%--66% bone volume); 3=severe (67%--100% bone volume).                                                                                                                                                                                                                                                                                                                               Coronal and axial. T2w-fs/STIR/PD-fs.

Table was reprinted with permission from Kroon *et al.* [@R1] All rights reserved.

†In longitudinal studies, 0.5 increments can be included to indicate within-grade change in synovitis, subchondral bone defects and bone marrow lesions.

‡Proximal and distal parts of joint are scored separately for subchondral bone defects, osteophytes and bone marrow lesions.

§Only the CMC-1 joint is evaluated for this feature.

¶If assessment of cartilage and cartilage space are in conflict, direct visualisation of the cartilage should be prioritised.

\*\*High signal intensity on STIR/T2w-fs images.

CMC-1, first carpometacarpal; fs, fat saturated; Gd, gadolinium-based contrast agent; GE, gradient echo; MC-1, first metacarpal; PD, proton density; OA, osteoarthritis; OMERACT, Outcome Measures in Rheumatology Clinical Trials; STIR,  Short   T1  Inversion   Recovery; STT, scapho-trapezio-trapezoid; TOMS, thumb base OA MRI scoring system; w, weighted.
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